First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia
- PMID: 26873444
- PMCID: PMC4752794
- DOI: 10.1186/s12967-016-0806-z
First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia
Abstract
As the human population continues to age, an increasing number of people will exhibit significant deficits in cognitive function and dementia. It is now recognized that cerebrovascular, metabolic and neurodegenerative diseases all play major roles in the evolution of cognitive impairment and dementia. Thus with our more recent recognition of these relationships and our need to understand and more positively impact on this world health problem, "The Leo and Anne Albert Charitable Trust" (Gene Pranzo, Trustee with significant support from Susan Brogan, Meeting Planner) provided generous support for this inaugural international workshop that was held from April 13-16, 2015 at the beautiful Ritz Carlton Golf Resort in North Naples, Florida. Researchers from SUNY Downstate Medical Center, Brooklyn, NY organized the event by selecting the present group of translationally inclined preclinical, clinical and population scientists focused on cerebrovascular disease (CVD) risk and its progression to vascular cognitive impairment (VCI) and dementia. Participants at the workshop addressed important issues related to aging, cognition and dementia by: (1) sharing new data, information and perspectives that intersect vascular, metabolic and neurodegenerative diseases, (2) discussing gaps in translating population risk, clinical and preclinical information to the progression of cognitive loss, and (3) debating new approaches and methods to fill these gaps that can translate into future therapeutic interventions. Participants agreed on topics for group discussion prior to the meeting and focused on specific translational goals that included promoting better understanding of dementia mechanisms, the identification of potential therapeutic targets for intervention, and discussed/debated the potential utility of diagnostic/prognostic markers. Below summarizes the new data-presentations, concepts, novel directions and specific discussion topics addressed by this international translational team at our "First Leo and Anne Albert Charitable Trust 'Think Tank' VCI workshop".
Similar articles
-
Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition.Geroscience. 2022 Feb;44(1):25-37. doi: 10.1007/s11357-021-00461-8. Epub 2021 Oct 4. Geroscience. 2022. PMID: 34606040 Free PMC article.
-
Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.Geroscience. 2020 Feb;42(1):81-96. doi: 10.1007/s11357-019-00141-8. Epub 2019 Dec 6. Geroscience. 2020. PMID: 31811528 Free PMC article. Review.
-
Vascular cognitive impairment: dementia biology and translational animal models.Curr Opin Investig Drugs. 2009 Jul;10(7):624-37. Curr Opin Investig Drugs. 2009. PMID: 19579168 Review.
-
The concept of vascular cognitive impairment.Front Neurol Neurosci. 2009;24:79-85. doi: 10.1159/000197886. Epub 2009 Jan 26. Front Neurol Neurosci. 2009. PMID: 19182465 Review.
-
Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.Acta Neurol Taiwan. 2007 Jun;16(2):86-91. Acta Neurol Taiwan. 2007. PMID: 17685132
Cited by
-
Pharmacotherapy for Vascular Cognitive Impairment.CNS Drugs. 2017 Sep;31(9):759-776. doi: 10.1007/s40263-017-0459-3. CNS Drugs. 2017. PMID: 28786085 Review.
-
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.J Alzheimers Dis. 2017;60(1):243-252. doi: 10.3233/JAD-170402. J Alzheimers Dis. 2017. PMID: 28826187 Free PMC article.
-
Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition.Geroscience. 2022 Feb;44(1):25-37. doi: 10.1007/s11357-021-00461-8. Epub 2021 Oct 4. Geroscience. 2022. PMID: 34606040 Free PMC article.
-
Carotid disease at age 73 and cognitive change from age 70 to 76 years: A longitudinal cohort study.J Cereb Blood Flow Metab. 2017 Aug;37(8):3042-3052. doi: 10.1177/0271678X16683693. Epub 2016 Jan 1. J Cereb Blood Flow Metab. 2017. PMID: 28155579 Free PMC article.
-
Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice.J Am Heart Assoc. 2018 Mar 26;7(7):e007694. doi: 10.1161/JAHA.117.007694. J Am Heart Assoc. 2018. PMID: 29581224 Free PMC article.
References
-
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939–944. doi: 10.1212/WNL.34.7.939. - DOI - PubMed
-
- Neuropathology Group Medical Research Council Cognitive Function and Aging Study—Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales—Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Lancet. 2001;357(9251):169–175. doi: 10.1016/S0140-6736(00)03589-3. - DOI - PubMed
-
- Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology. 1993;43(2):250–260. doi: 10.1212/WNL.43.2.250. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous